|
|
P.O. Box 708, 1800 West Center Street Warsaw, IN 46581-0708 USA phone:800-613-6131 fax:574-372-4330
|
|
| Symbol |
ZMH |
| Exchange |
NYSE |
| Founded |
1927 |
| Employees |
6500 |
|
|
| www.zimmer.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Hip replacement, knee replacement solutions |
 |
| Management |
| David Dvorak, ceo; James Crines, Executive Vice President and CFO; Paul Blair, Vice President, Investor Relations; James T. Crines, EVP, Finance and CFO; Cheryl R. Blanchard, Ph.D.Senior Vice President, Research and Development and Chief Scientific Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| aluminum splints, orthopaedic surgeons, warsaw, toiletries, linens |
|
|
|
| Description |
|
Zimmer is a worldwide leader in joint replacement solutions for knee pain and hip pain, and provides comprehensive spine care solutions for acute and chronic back pain. The company also provides a broad range of trauma, dental implant, and orthopaedic surgical products. Founded in 1927, Zimmer is committed to providing effective techniques in hip replacement and knee replacement for orthopaedic surgeons who restore mobility and relieve the pain of osteoarthritis and traumatic injuries. Their minimally invasive hip and minimally invasive knee replacement systems and wide range of related products and services have helped them become valuable partners to health-care providers in more than 80 countries. |
 |
| Products / Services |
Zimmer's world leadership in reconstructive orthopaedics is built on leading positions in both hips and knees. Their extensive product portfolio offers surgeons a wide range of options for reconstructive orthopaedics. They are continually developing new products to reach the full spectrum of patients on the continuum of care, from younger patients with early-stage joint problems to older patients who need to replace an existing implant. Notable products include: Dyanesys, TransFX External Fixation System, Metasul, NexGen CR-Flex Fixed Bearing Knee, CPT 12/14 Hip, Rotator Cuff Repair Patch, spinal fusion with the ST360 TM System or SilhouetteTM Pedicle Screw System.
|
 |
| Technology / Differentiation |
| Millions of patients now enjoy the benefits of total joint arthroplasty, which has evolved into a ?routine? procedure during more than five decades of clinical development and application. Yet the tangible patient benefits of less pain and greater mobility were offset in some cases by a new disease?periprosthetic osteolysis?associated with small particles of foreign materials, especially polyethylene, within the human body. As the etiology and manifestations of osteolysis have been elucidated, so too has been the need for more robust orthopaedic materials and designs. thus began the search for alternative bearings, articulating couples whose in vivo performance would rival the historical metal-on-conventional polyethylene couple. Key to the quest for improved performance is tribology?the science of the mechanisms of friction, lubrication, and wear of interacting surfaces. |
 |
| Market / Customers |
The Company's primary customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent surgeons.
|
 |
| Competitors / Substitutes / Alternatives |
Biomet Inc (BMET), Smith & Nephew PLC (SNN), Stryker Corp (SYK)
|
 |
| Strategy |
As the largest pure-play orthopaedics company in the world, and with access to Centerpulse's interbody fusion cages, surgical instruments and spinal allograft and bone materials, Zimmer is poised to become a major player in spine surgery. They are investing heavily in biologics, intellectual property and proprietary technology. However, they are not rushing to market with an artificial disc -- why? President and CEO Elliott suspects the market may not be as lucrative initially as projected due to patient-product mis-match lawsuits. As a result, Zimmer is developing a second- or third-generation product that will have stronger technology than earlier models and be more likely used on the right patients.
|
 |
|
|
|
|
|
|